Brought to you by 
RDO nets $9.3mm for Neuralstem
28 Apr 2021
Executive Summary
CNS-focused Neuralstem Inc. netted $9.3mm through the registered direct offering of 3.57mm units priced at $2.80 each (a 14% discount) to institutional investors. Each unit consists of one common share and 3/4 of a common stock purchase warrant. The three-year warrants are exercisable at $3.25. Noble Financial Capital Markets was the placement agent.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Gene Therapy, Cell Therapy
Deal Status
- Final
Deal Type
-
Financing
- Private Investment in Public Equity
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
RDO nets $9.3mm for Neuralstem
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice